Novel Benzimidazole/Hydrazone Derivatives as Promising Anticancer Lead Compounds: Design, Synthesis, and Molecular Docking Study
Last updated: 23 Dec 2024
10.21608/jabps.2020.21160.1064
Benzimidazole, hydrazone, Anti-cancer, Molecular docking
Martha
Morcoss
M.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, 62513 New Beni Suef, Egypt
martha.moheb@nub.edu.eg
El Shimaa
Abdelhafez
M. N.
Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt
shimaanaguib_80@mu.edu.eg
Hamdy
Abdel-Rahman
M.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, 62513 New Beni Suef, Egypt, Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, 71526 Assiut, Egypt
hamdy.abdelrahman@nub.edu.eg
Mohamed
Abdel-Aziz
Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt
abulnil@hotmail.com
Minia
Dalal
Abou El-Ella
A.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, 11566 Abbassia, Cairo, Egypt
dalal.abdelrahman@nub.edu.eg
cairo
3
2
11874
2020-04-01
2019-12-18
2020-04-01
45
52
2535-1869
2535-2040
https://jabps.journals.ekb.eg/article_70782.html
https://jabps.journals.ekb.eg/service?article_code=70782
1
Original Article
522
Journal
Journal of advanced Biomedical and Pharmaceutical Sciences
https://jabps.journals.ekb.eg/
Novel Benzimidazole/Hydrazone Derivatives as Promising Anticancer Lead Compounds: Design, Synthesis, and Molecular Docking Study
Details
Type
Article
Created At
22 Jan 2023